Division of Gastroenterology & Hepatology Research | NYU Langone Health

Division of Gastroenterology & Hepatology Research

We conduct research to better care for current and future patients with gastrointestinal and liver conditions.

Our research goals at NYU Langone’s Division of Gastroenterology and Hepatology are to provide access to the latest treatments in the pipeline to our patients and to advance knowledge of gastroenterology and hepatology through innovative basic science, translational research, and clinical trials. We aim to foster a spirit of scientific inquiry and innovation among faculty, fellows, and students.

Our researchers study the biology, prevention, diagnosis, and treatment of gastrointestinal (GI) and liver diseases. Among our current areas of research are the following:

  • role of the gut microbiome in health and the pathogenesis of disease such as colorectal cancer, liver cancer, and fatty liver and other diseases
  • role of GI infection and gut microbial dysbiosis in the pathogenesis of inflammatory bowel disease
  • quality and innovations in enhanced technologies for colon cancer screening
  • bariatric endoscopy outcomes in obesity and fatty liver disease
  • clinical trials in all areas of liver disease, inflammatory bowel disease, colorectal cancer screening and prevention, and other GI conditions
  • cirrhosis and hepatitis C infection

Select Faculty Publications

Esophageal Disorders in the Older Adult

Babbar, Shaili; Sachar, Moniyka; Faye, Adam; Knotts, Rita M

Current treatment options in gastroenterology. 2025 Dec ; 23:

Right-Sided Dysplasia in Inflammatory Bowel Disease Is Not Associated with Conventional Risk Factors for Neoplasia

Bhattacharya, Sumona; Beaty, William; Faye, Adam S; Axelrad, Jordan E

Gastroenterology insights. 2025 Jun ; 16:

Clin-STAR Corner: Practice-Changing Advances at the Interface of Gastroenterology & Geriatrics

Faye, Adam S; Kochar, Bharati; Shaukat, Aasma

Journal of the American Geriatrics Society. 2025 Apr 09;

Identification of patients at risk for pancreatic cancer in a 3-year timeframe based on machine learning algorithms

Zhu, Weicheng; Chen, Long; Aphinyanaphongs, Yindalon; Kastrinos, Fay; Simeone, Diane M; Pochapin, Mark; Stender, Cody; Razavian, Narges; Gonda, Tamas A

Scientific reports. 2025 Apr 05; 15:11697

Optimizing Bowel Preparation Quality for Colonoscopy: Consensus Recommendations by the US Multi-Society Task Force on Colorectal Cancer

Jacobson, Brian C; Anderson, Joseph C; Burke, Carol A; Dominitz, Jason A; Gross, Seth A; May, Folasade P; Patel, Swati G; Shaukat, Aasma; Robertson, Douglas J

The American journal of gastroenterology. 2025 Apr 01; 120:738-764

Safety of Immunosuppression in A Prospective Cohort of Inflammatory Bowel Disease Patients with a HIstoRy of CancEr: SAPPHIRE Registry

Itzkowitz, Steven H; Jiang, Yue; Villagra, Cristina; Colombel, Jean-Frederic; Sultan, Keith; Lukin, Dana J; Faleck, David M; Scherl, Ellen; Chang, Shannon; Chen, LeaAnn; Katz, Seymour; Kwah, Joann; Swaminath, Arun; Petralia, Francesca; Sharpless, Virginia; Sachar, David; Jandorf, Lina; Axelrad, Jordan E; ,

Clinical gastroenterology & hepatology. 2025 Apr ; 23:855-865.e5

Revolutionizing Gastrointestinal Endoscopy: Artificial Intelligence's Transformative Role [Editorial]

Gross, Seth A

Gastrointestinal endoscopy clinics of North America. 2025 Apr ; 35:xv-xvi

Optimizing bowel preparation quality for colonoscopy: consensus recommendations by the US Multi-Society Task Force on Colorectal Cancer

Jacobson, Brian C; Anderson, Joseph C; Burke, Carol A; Dominitz, Jason A; Gross, Seth A; May, Folasade P; Patel, Swati G; Shaukat, Aasma; Robertson, Douglas J

Gastrointestinal endoscopy. 2025 Apr ; 101:702-732